DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,807,682 | -3.6% | 19,378 | -6.8% | 0.18% | +4.8% |
| Q2 2023 | $4,987,920 | -8.2% | 20,783 | -3.6% | 0.17% | -8.2% |
| Q1 2023 | $5,431,210 | +247.2% | 21,549 | +265.6% | 0.18% | +256.9% |
| Q4 2022 | $1,564,385 | +1.9% | 5,894 | -0.8% | 0.05% | -5.6% |
| Q3 2022 | $1,535,000 | -4.4% | 5,941 | -6.2% | 0.05% | +12.5% |
| Q2 2022 | $1,606,000 | -13.9% | 6,334 | -0.5% | 0.05% | -5.9% |
| Q1 2022 | $1,866,000 | -10.3% | 6,363 | +0.6% | 0.05% | -7.3% |
| Q4 2021 | $2,081,000 | -28.5% | 6,325 | -33.9% | 0.06% | -34.5% |
| Q3 2021 | $2,912,000 | +40.7% | 9,564 | +24.0% | 0.08% | +40.0% |
| Q2 2021 | $2,070,000 | +6.0% | 7,714 | -11.1% | 0.06% | +1.7% |
| Q1 2021 | $1,953,000 | -6.6% | 8,675 | -7.9% | 0.06% | -10.6% |
| Q4 2020 | $2,091,000 | -0.1% | 9,415 | -3.2% | 0.07% | -10.8% |
| Q3 2020 | $2,094,000 | +23.8% | 9,724 | +1.7% | 0.07% | +17.5% |
| Q2 2020 | $1,691,000 | +22.3% | 9,564 | -4.3% | 0.06% | +6.8% |
| Q1 2020 | $1,383,000 | -10.4% | 9,994 | -0.6% | 0.06% | +15.7% |
| Q4 2019 | $1,543,000 | +2.3% | 10,053 | -3.7% | 0.05% | -1.9% |
| Q3 2019 | $1,508,000 | +1.3% | 10,442 | +0.2% | 0.05% | +6.1% |
| Q2 2019 | $1,489,000 | -75.6% | 10,421 | -77.5% | 0.05% | -74.3% |
| Q1 2019 | $6,102,000 | +7.7% | 46,219 | -15.9% | 0.19% | -1.0% |
| Q4 2018 | $5,665,000 | -8.6% | 54,939 | -3.6% | 0.19% | +4.9% |
| Q3 2018 | $6,195,000 | +8.8% | 57,014 | -1.2% | 0.18% | +5.7% |
| Q2 2018 | $5,693,000 | -0.3% | 57,693 | -1.1% | 0.17% | -5.4% |
| Q1 2018 | $5,710,000 | +5.4% | 58,323 | -0.1% | 0.18% | +2.8% |
| Q4 2017 | $5,419,000 | +7.9% | 58,383 | -0.3% | 0.18% | +4.7% |
| Q3 2017 | $5,021,000 | +1.6% | 58,533 | -0.0% | 0.17% | -4.5% |
| Q2 2017 | $4,941,000 | -1.5% | 58,553 | -0.2% | 0.18% | -3.2% |
| Q1 2017 | $5,018,000 | -26.4% | 58,674 | -33.0% | 0.18% | -32.0% |
| Q4 2016 | $6,821,000 | +77.3% | 87,633 | +78.6% | 0.27% | +77.8% |
| Q3 2016 | $3,847,000 | -22.1% | 49,078 | +0.4% | 0.15% | -25.0% |
| Q2 2016 | $4,936,000 | +1.4% | 48,868 | -4.7% | 0.20% | 0.0% |
| Q1 2016 | $4,866,000 | +2.8% | 51,293 | +0.6% | 0.20% | +1.0% |
| Q4 2015 | $4,733,000 | +12.8% | 50,963 | +3.5% | 0.20% | +9.8% |
| Q3 2015 | $4,197,000 | -7.3% | 49,258 | -6.9% | 0.18% | -1.1% |
| Q2 2015 | $4,529,000 | +4.5% | 52,918 | +3.7% | 0.19% | +1.1% |
| Q1 2015 | $4,333,000 | -1.0% | 51,038 | -0.0% | 0.18% | -14.0% |
| Q4 2014 | $4,375,000 | +11.9% | 51,048 | -0.8% | 0.21% | +4.4% |
| Q3 2014 | $3,911,000 | -3.6% | 51,478 | -0.2% | 0.20% | -5.1% |
| Q2 2014 | $4,059,000 | +3.2% | 51,558 | -1.7% | 0.22% | -6.5% |
| Q1 2014 | $3,933,000 | -0.5% | 52,438 | +2.5% | 0.23% | -5.7% |
| Q4 2013 | $3,951,000 | +18.6% | 51,178 | +6.5% | 0.24% | -4.7% |
| Q3 2013 | $3,330,000 | +10.6% | 48,038 | +0.9% | 0.26% | +3.2% |
| Q2 2013 | $3,012,000 | – | 47,588 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |